Prof. Deanfield and prof. Hobbs discuss the shift in focus from treating patients with clinical problems arising from established CV disease to CV prevention in patients with risk factors for developing CV disease.
|
Prof. Richard Hobbs gives an overview of highlights from EPCCS 2011, with a summary of sessions that were held, e.g. concerning lifetime cardiovascular risk, hypertension, diabetes, and chronic kidney disease.
|
Prof. Richard McManus discusses the shift in diagnosis of hypertension from clinic measurement to ambulatory and home measurement.
|
Prof. Pierre Amarenco discusses the importance of early recognition and treatment of TIAs to ensure a better prognosis.
|
Dr. Neil Munro discusses several new developments in diabetes relevant for primary care.
|
Dr. Frans Rutten clarifies which symptoms are suspicious for heart failure and which tests can be used .
|
Prof. Martin R. Cowie
Good HF management does require a team approach. A nurse-led multidisciplinary programme could be of added value to patients.
|
Prof. Martin R. Cowie, Imperial College, London, United Kingdom
There have been two very important randomized trials in the field of heart failure in the past 12 months, which should have an impact in everybody’s practice.
|